Episode Details

Back to Episodes
InnoCare Pharma PSMA/STEAPone dual antibody ADC ICP-Bthree hundred and eighty-one approved

InnoCare Pharma PSMA/STEAPone dual antibody ADC ICP-Bthree hundred and eighty-one approved

Published 2 days, 5 hours ago
Description
Smf5Yv7iSAZW7lGwgunC
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us